↓ Skip to main content

Cochrane Database of Systematic Reviews

Rituximab for rheumatoid arthritis

Overview of attention for article published in Cochrane database of systematic reviews, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter
17 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
186 Mendeley
Title
Rituximab for rheumatoid arthritis
Published in
Cochrane database of systematic reviews, January 2015
DOI 10.1002/14651858.cd007356.pub2
Pubmed ID
Authors

Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono, Maria E Suarez-Almazor

Abstract

Rituximab is a selective, B-cell depleting, biologic agent for treating refractory rheumatoid arthritis (RA). It is a chimeric monoclonal antibody targeted against CD 20 that is promoted as therapy for patients who fail to respond to other biologics. There is evidence to suggest that rituximab is effective and well tolerated when used in combination with methotrexate for RA.

Twitter Demographics

The data shown below were collected from the profiles of 17 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
Sri Lanka 1 <1%
South Africa 1 <1%
Brazil 1 <1%
Unknown 182 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 46 25%
Student > Ph. D. Student 26 14%
Student > Bachelor 22 12%
Researcher 14 8%
Student > Postgraduate 13 7%
Other 31 17%
Unknown 34 18%
Readers by discipline Count As %
Medicine and Dentistry 83 45%
Nursing and Health Professions 12 6%
Psychology 11 6%
Pharmacology, Toxicology and Pharmaceutical Science 10 5%
Biochemistry, Genetics and Molecular Biology 9 5%
Other 20 11%
Unknown 41 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 June 2021.
All research outputs
#1,970,485
of 18,812,670 outputs
Outputs from Cochrane database of systematic reviews
#4,554
of 11,865 outputs
Outputs of similar age
#33,638
of 305,515 outputs
Outputs of similar age from Cochrane database of systematic reviews
#108
of 236 outputs
Altmetric has tracked 18,812,670 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,865 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.6. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.